Literature DB >> 18286695

Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis.

Nuket Mas1, Ilker Tasci, Bilgin Comert, Ramazan Ocal, Mehmet Refik Mas.   

Abstract

AIM: To examine the ultrastructural changes after ursodeoxycholic acid (UDCA) treatment in hepatocytes from experimentally induced fibrotic livers.
METHODS: Liver fibrosis was induced in male Sprague-Dawley rats with CCl4 for 12 wk, and the rats were divided into two groups. Group I was treated with saline and group II with UDCA (25 mg/kg per day) for 4 wk. All the rats were killed at wk 16. Mitochondria, nuclei, rough endoplasmic reticulum (RER) and smooth endoplasmic reticulum (SER) of hepatocytes were evaluated according to a scoring system.
RESULTS: Mitochondria, nuclei, RER and SER injury scores in group II were significantly lower than those in group I (P < 0.001).
CONCLUSION: UDCA alleviates hepatocyte organelle injury in CCl4-induced liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286695      PMCID: PMC2689416          DOI: 10.3748/wjg.14.1108

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

Review 1.  Hepatic stellate cells as a target for the treatment of liver fibrosis.

Authors:  R Bataller; D A Brenner
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

2.  The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.

Authors:  C Corpechot; F Carrat; A M Bonnand; R E Poupon; R Poupon
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

Review 3.  The cell biology of liver fibrogenesis - an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts.

Authors:  A M Gressner
Journal:  Cell Tissue Res       Date:  1998-06       Impact factor: 5.249

4.  Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.

Authors:  C M Rodrigues; G Fan; P Y Wong; B T Kren; C J Steer
Journal:  Mol Med       Date:  1998-03       Impact factor: 6.354

5.  Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis.

Authors:  H Koga; S Sakisaka; M Ohishi; M Sata; K Tanikawa
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

6.  Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.

Authors:  J L Poo; G Feldmann; S Erlinger; A Braillon; C Gaudin; M Dumont; D Lebrec
Journal:  Gastroenterology       Date:  1992-05       Impact factor: 22.682

7.  Acinar cell ultrastructure after taurine treatment in rat acute necrotizing pancreatitis.

Authors:  Yuksel Ates; Mehmet R Mas; Nuket Mas; Ilker Tasci; Bilgin Comert; Ahmet T Isik; Nuran Yener
Journal:  Saudi Med J       Date:  2006-04       Impact factor: 1.484

8.  An electron microscopic and morphometric study of ursodeoxycholic effect in primary biliary cirrhosis.

Authors:  Manuela G Neuman; Ross G Cameron; Julia A Haber; Gady G Katz; Laurence M Blendis
Journal:  Liver       Date:  2002-06

9.  Balance between oxidative damage and proliferative potential in an experimental rat model of CCl4-induced cirrhosis: protective role of adenosine administration.

Authors:  R Hernández-Muñoz; M Díaz-Muñoz; V López; F López-Barrera; L Yáñez; S Vidrio; A Aranda-Fraustro; V Chagoya de Sánchez
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

10.  A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.

Authors:  C M Rodrigues; G Fan; X Ma; B T Kren; C J Steer
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

View more
  4 in total

1.  Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioacetamide-induced Rat Liver Fibrosis.

Authors:  Vyacheslav U Buko; Oxana Y Lukivskaya; Elena E Naruta; Elena B Belonovskaya; Horst-Dietmar Tauschel
Journal:  J Clin Exp Hepatol       Date:  2014-02-21

Review 2.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

3.  Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury.

Authors:  Ilker Tasci; Nuket Mas; Mehmet-Refik Mas; Murvet Tuncer; Bilgin Comert
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

4.  A Herbal Formula, CGXII, Exerts Antihepatofibrotic Effect in Dimethylnitrosamine-Induced SD Rat Model.

Authors:  Hyo-Seon Kim; Hyeong-Geug Kim; Hye-Won Lee; Sung-Bae Lee; Jin-Seok Lee; Hwi-Jin Im; Won-Yong Kim; Dong-Soo Lee; Chang-Gue Son
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-29       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.